"The UK government invests in research and development due to the economic benefits of research and development for the UK. Working with industry demonstrates very clearly…
In Conversation
One of our key challenges is to show impact, and determine how we are using our research, influence, and money to accelerate treatment
"The only way growth will be substantial is when peers question each other on the most effective ways of getting a job done. It is all…
"One of the tremendous advantages we have in Britain is that we possess three world-leading assets: our National Health Service, a thriving life sciences sector, and…
"We are building specialist capabilities in the UK with a focus on market access and we also lead several access projects across Europe from the UK…
"By the time that my grandchildren approach my age, they will regard healthcare nowadays as no different from bleeding someone for a fever in the Middle…
Our vision is to be the voice of the health and medical research charity sector, supporting them in their delivery of high quality research, and championing…
Although the MS community is fairly small, the science is telling us that with a fair wind, smart focus, good innovation and global collaboration, we should…
In all the neurodegenerative diseases, we have to get better in identifying people earlier. Detection is crucial before they are sick. Genetics is a big part…
"The generics industry brings an enormous amount of value to the UK economy, to patients, to the NHS, and to everything around these products."
"My major concern is investment into R&D in the UK universities and the fact European funding will disappear."
"Self-care is one of our core pillars. We want to empower more people to self-care more of the time."
